Findings

What do systematic reviews say?

7 questions · 7 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 1 · 14.3%Low 1 · 14.3%Moderate 5 · 71.4%High 0 · 0%

Combination inhaled therapy vs SABA

Hospital admissions · Adults with acute asthma

Combination inhaled therapy probably leads to lower hospitalisation compared with SABA alone (moderate certainty).

1 finding from 1 review

Combined inhaled beta‐agonist and anticholinergic agents for emergency management in adults with asthma 2017 · Cochrane Headline outcomes only
RR 0.72 [0.59, 0.86]
16 studies · 2120 participants
Moderate

Combination inhaled therapy vs SABA

Total adverse events · Adults with acute asthma

Combination inhaled therapy probably leads to higher total adverse events compared with SABA alone (moderate certainty).

1 finding from 1 review

Combined inhaled beta‐agonist and anticholinergic agents for emergency management in adults with asthma 2017 · Cochrane Headline outcomes only
OR 2.03 [1.28, 3.2]
11 studies · 1392 participants
Moderate

Combination inhaled therapy vs SABA

FEV1 · Adults with acute asthma

1 finding from 1 review

Combined inhaled beta‐agonist and anticholinergic agents for emergency management in adults with asthma 2017 · Cochrane Headline outcomes only
no estimate extracted
6 studies · 687 participants
Low

Combination inhaled therapy vs SABA

Percent change FEV₁(%) · Adults with acute asthma

1 finding from 1 review

Combined inhaled beta‐agonist and anticholinergic agents for emergency management in adults with asthma 2017 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 578 participants
Very low

Combination inhaled therapy vs SABA

Health outcomes Peak expiratory flow readings (higher readings indicate better peak flow) · Adults with acute asthma

1 finding from 1 review

Combined inhaled beta‐agonist and anticholinergic agents for emergency management in adults with asthma 2017 · Cochrane Headline outcomes only
no estimate extracted
12 studies · 1056 participants
Moderate

Combination inhaled therapy vs SABA

Change in PEF · Adults with acute asthma

1 finding from 1 review

Combined inhaled beta‐agonist and anticholinergic agents for emergency management in adults with asthma 2017 · Cochrane Headline outcomes only
no estimate extracted
7 studies · 551 participants
Moderate

Combination inhaled therapy vs SABA

Relapse · Adults with acute asthma

Combination inhaled therapy probably leads to lower relapse rates compared with SABA alone (moderate certainty).

1 finding from 1 review

Combined inhaled beta‐agonist and anticholinergic agents for emergency management in adults with asthma 2017 · Cochrane Headline outcomes only
RR 0.8 [0.66, 0.98]
5 studies · 1180 participants
Moderate